Skip to content
PepFitCoach™

GLP-1 safe-use coaching

Your prescriber sets the dose.
We build the habits.

Practical, evidence-informed coaching for people taking a prescribed GLP-1: eating with a smaller appetite, staying hydrated, keeping muscle, and knowing when to call your clinician.
Read the safety checklistGLP-1 strength guide

Low and slow step-up

  1. 0.25 mg
  2. 0.5 mg
  3. 1 mg
  4. 1.7 mg
  5. 2.4 mg

At least 4 weeks per step, 4–8 if side effects are rough. Your prescriber sets every dose.

Your GLP-1 safety questions, answered

Blindness, cancer, eye disease, the thyroid warning and the newer amylin medicines, in plain words.

Do GLP-1s make you blind?Very rarely, a sudden optic-nerve problem has been linked to semaglutide. Blindness is not a common side effect.
  • The condition is NAION, a sudden loss of blood flow to the optic nerve that causes painless vision loss, usually in one eye.
  • Some studies found it more often in people taking semaglutide. In 2025 the European Medicines Agency concluded it is a very rare side effect, affecting up to about 1 in 10,000 people.
  • Your risk is higher if you already have diabetes, high blood pressure, sleep apnea or a crowded optic nerve.

Sudden vision loss or blurring in one eye is an emergency: get care right away and tell your prescriber.

Can they make diabetic eye disease worse?Yes, if you already have diabetic retinopathy and your blood sugar drops quickly. That's why an eye exam comes first.
  • In the SUSTAIN-6 trial of semaglutide, more people with existing diabetic retinopathy had it get worse (about 3% vs 1.8% on placebo), mostly when blood sugar fell fast.
  • Quick improvement in blood sugar can briefly worsen damaged retinal blood vessels before they settle.
  • This is about existing diabetic eye disease, not people without diabetes.

Have diabetes? Get a dilated eye exam before starting, tell your eye doctor you're starting a GLP-1, and keep regular checkups.

Do GLP-1s cause cancer?There's no clear proof they cause cancer in people. The one firm warning is about a rare thyroid cancer.
  • In rats and mice, semaglutide and tirzepatide caused thyroid C-cell tumors. Whether this happens in people is not known; large human studies so far have not confirmed it.
  • Studies have not shown a clear rise in pancreatic cancer. Some studies even link GLP-1s with fewer obesity-related cancers, but that isn't proven.
  • Research is ongoing, so report any lump in the neck, trouble swallowing, hoarseness or shortness of breath.
Who must NOT take a GLP-1: the MTC and MEN 2 warningDon't use GLP-1 medicines if you or a family member has had medullary thyroid cancer (MTC), or if you have MEN 2.
  • This is a boxed warning on semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro, Zepbound) and other long-acting GLP-1 medicines.
  • MTC is a rare thyroid cancer that comes from C-cells. MEN 2 is an inherited condition that causes it.
  • Investigational medicines that include GLP-1 activity (retatrutide, survodutide, CagriSema) are expected to carry the same caution.

Tell your prescriber about any thyroid cancer in your family before starting.

Is eloralintide different? And cagrilintide?Yes: they're amylin medicines, not GLP-1s. The GLP-1 thyroid warning isn't expected to apply the same way, but they're still investigational.
  • Eloralintide (Lilly) and cagrilintide (Novo Nordisk) copy amylin, a fullness hormone your pancreas makes along with insulin. They don't act on GLP-1 receptors, which is where the thyroid C-cell concern comes from.
  • The one approved amylin medicine, pramlintide (Symlin, for diabetes since 2005), does not carry the MTC or MEN 2 warning. Its main warning is low blood sugar when used with insulin.
  • But eloralintide and cagrilintide are not approved anywhere. Their long-term safety, including for people with MTC or MEN 2, is not yet known, so no one can promise they're safe for you.
  • CagriSema combines cagrilintide with semaglutide, so because of the semaglutide part it carries the GLP-1 thyroid caution.

Have a personal or family history of MTC or MEN 2? Talk to an endocrinologist before any weight-loss medicine, approved or not.

Based on FDA prescribing information, the SUSTAIN-6 trial and the European Medicines Agency's 2025 review. Educational only; your prescriber and eye doctor know your situation.

Must read before you start

GLP-1 risks: what's real and what's hype

You may have seen scary headlines about cancer, pancreatitis, blindness or your heart. Here is the honest picture, first in simple words, then the detail.

  1. 1

    Thyroid cancer

    In simple words: Animal studies raised a flag. People with one specific family thyroid cancer history must avoid these medicines.

    In rats and mice, semaglutide and tirzepatide caused thyroid C-cell tumors. It is not known whether they do this in people, and no causal link has been confirmed in humans. Because of the animal findings, they should not be used by anyone with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia type 2 (MEN 2).

    What to do: Tell your prescriber about a neck lump, hoarseness, trouble swallowing or shortness of breath.

  2. 2

    Pancreatitis

    In simple words: Uncommon, but know the warning pain.

    Acute pancreatitis has been reported in people taking GLP-1 medicines, but it is uncommon. The risk is higher if you have had pancreatitis before, gallstones, very high triglycerides or heavy alcohol use, so share that history before starting.

    What to do: Severe upper-belly pain that won't go away, sometimes spreading to the back, with or without vomiting: stop and get urgent care.

  3. 3

    Gallbladder problems

    In simple words: Losing weight fast can cause gallstones.

    Rapid weight loss raises the chance of gallstones, and gallbladder problems were reported more often with these medicines in trials.

    What to do: Pain in the upper right belly, fever, yellow skin or eyes, or clay-colored stools: contact a clinician promptly.

  4. 4

    Vision changes

    In simple words: Keep up eye exams if you have diabetes. Sudden vision loss is an emergency.

    Fast improvement in blood sugar can temporarily worsen existing diabetic retinopathy, so people with diabetes need regular eye exams. Separately, a rare optic-nerve condition called NAION (sudden, usually painless vision loss in one eye) has been linked to semaglutide; in 2025 the European Medicines Agency listed it as a very rare side effect, affecting up to about 1 in 10,000 people.

    What to do: Any sudden loss or blurring of vision: get emergency care and tell your prescriber.

  5. 5

    Heart rate

    In simple words: A slightly faster pulse is common. A racing or irregular heartbeat is not; report it.

    In clinical trials GLP-1 medicines raised resting heart rate by a few beats per minute on average; a similar, dose-related rise was seen with investigational medicines such as retatrutide. Tracking your resting heart rate helps you and your prescriber spot changes.

    What to do: Palpitations, a racing heart at rest, chest pain or fainting: contact your prescriber or get urgent care.

Key takeaway: These are rule-outs and cautions, not automatic reasons to avoid treatment. Know who should not take these medicines, know the warning signs, keep your bloodwork up to date, and work with a prescriber you can talk to openly.

Who does what

Your prescriber

  • Decides whether a GLP-1 medicine is appropriate for you
  • Chooses the medicine, the dose and the titration schedule
  • Reviews your history, other medications and lab results
  • Manages side effects and decides when to pause or stop

Your health coach

  • Builds eating habits that work with a smaller appetite
  • Plans strength training to help preserve muscle
  • Supports hydration, sleep and daily movement
  • Helps you track symptoms to discuss with your prescriber

Safety checklist

  1. 01

    Use only prescribed, FDA-approved products

    Get GLP-1 medicines only with a prescription, filled by a state-licensed pharmacy. FDA has warned about counterfeit, unapproved and online "research" versions, and about dosing errors with compounded products.

  2. 02

    Never self-adjust your dose

    Follow the titration schedule your prescriber gives you. Do not increase, split, skip or restart doses on your own; ask your prescriber what to do after a missed dose.

  3. 03

    Share your full health history

    Tell your prescriber about thyroid cancer in you or your family, pancreatitis, gallbladder disease, kidney problems, diabetic eye disease, pregnancy plans and every other medicine you take.

  4. 04

    Eat smaller meals and stop when full

    Smaller portions, eating slowly and limiting high-fat or greasy meals can make nausea more manageable. Prioritize protein first at each meal.

  5. 05

    Stay hydrated

    Vomiting and diarrhea can cause dehydration, which can affect the kidneys. Sip fluids through the day and contact your prescriber if GI symptoms persist.

  6. 06

    Protect your muscle

    Weight loss includes some lean mass. Resistance training two to three times per week and adequate protein are the main tools to limit muscle loss.

  7. 07

    Mention it before surgery or procedures

    GLP-1 medicines slow stomach emptying. Tell your surgeon and anesthesia team you take one before any procedure involving sedation.

  8. 08

    Plan ahead for pregnancy

    Talk to your prescriber before trying to conceive. Some labels advise stopping well before a planned pregnancy.

Common side effects

Often most noticeable when starting or after a dose increase. Report them to your prescriber.

  • Nausea
  • Vomiting
  • Diarrhea
  • Constipation
  • Abdominal discomfort
  • Reduced appetite
  • Fatigue

Get medical help promptly if you notice

  • Severe stomach pain that does not go away, with or without vomiting (possible pancreatitis)
  • Pain in the upper right abdomen, fever, yellowing of the skin or eyes, or clay-colored stools (possible gallbladder problem)
  • A lump or swelling in the neck, trouble swallowing, hoarseness or shortness of breath
  • Swelling of the face, lips or throat, or trouble breathing (allergic reaction)
  • Vomiting or diarrhea that stops you keeping fluids down, or greatly reduced urination
  • Signs of low blood sugar if you also take insulin or a sulfonylurea: shakiness, sweating, confusion, fast heartbeat
  • New or worsening depression, or thoughts of self-harm

In an emergency, call 911 or your local emergency number.

Boxed warning

Semaglutide and tirzepatide labels carry a boxed warning: these medicines caused thyroid C-cell tumors in rodents. It is not known whether they do in people. They should not be used by people with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

About “research peptides” and other peptides

Products sold online as "research peptides" or "not for human consumption" (including semaglutide, tirzepatide and retatrutide) are not approved medicines. Their identity, purity, sterility and dose are not verified, and retatrutide is not approved anywhere. I do not provide dosing protocols for these products.

For the evidence on other peptides, see the research library.

Low and slow: how a safe step-up works

In simple words: start on the smallest dose, stay on each step for at least 4 weeks (4–8 if you need it), and only go up when you feel OK. Your prescriber sets every dose; this helps you know what to ask for.

  1. 1

    Start low

    Everyone starts at the lowest dose. It isn't meant to cause weight loss yet; it lets your stomach and brain get used to the medicine.

  2. 2

    Go slow: 4–8 weeks per step

    The labels use at least 4 weeks on each dose before going up. If you're still having side effects, many people do better staying 4–8 weeks, or longer, on a step. There's no prize for getting to the top dose fast.

  3. 3

    Side effects bad? Step back or take a smaller jump

    Ask your prescriber about going back to the last dose you felt OK on, staying there longer, or a smaller in-between step instead of the full jump. Never change your dose on your own.

  4. 4

    The right dose is the lowest one that works

    If you're losing weight steadily and feeling well, you may not need to go higher. Talk to your prescriber before every increase.

The standard step-up ladders

What your prescriber usually starts from. Each step is at least 4 weeks.

Semaglutide (Wegovy) · mg once a week

  1. 0.25 mg250 mcg
  2. 0.5 mg500 mcg
  3. 1 mg1,000 mcg
  4. 1.7 mg1,700 mcg
  5. 2.4 mg2,400 mcg

Tirzepatide (Zepbound, Mounjaro) · mg once a week

  1. 2.5 mg2,500 mcg
  2. 5 mg5,000 mcg
  3. 7.5 mg7,500 mcg
  4. 10 mg10,000 mcg
  5. 12.5 mg12,500 mcg
  6. 15 mg15,000 mcg

Each step is at least 4 weeks on the label. Your prescriber may keep you on a step longer, or stop at a lower dose that works. Source: FDA prescribing information for Wegovy and Zepbound.

mg vs mcg, explained

mg (milligram) and mcg (microgram) are both weights. A microgram is 1,000 times smaller than a milligram: 1 mg = 1,000 mcg.

Milligrams (mg)Micrograms (mcg)
0.25 mg= 250 mcg
0.5 mg= 500 mcg
1 mg= 1,000 mcg
2.5 mg= 2,500 mcg
  • So 0.5 mg and 500 mcg are exactly the same dose, just written two ways.
  • To turn mg into mcg, multiply by 1,000. To turn mcg into mg, divide by 1,000.
  • mL and “units” on a syringe measure liquid, not medicine. How much medicine is in each mL depends on the vial's strength, so the same mL can be a very different dose.
  • FDA has warned about overdoses with compounded semaglutide caused by mix-ups between mg, mL and units. Always ask your pharmacist to confirm your dose in mg and exactly how much to draw up.

Side effects after a dose increase?

A slower step-up is often the answer

Nausea, vomiting, constipation and fatigue are most common in the weeks right after a dose increase. Moving up too quickly is one of the main reasons people struggle or quit.

  • You don't have to push through rough side effects. Prescribing information lets prescribers delay the next dose increase if a dose isn't tolerated; the Wegovy label, for example, suggests considering a 4-week delay.
  • Some people do better staying on a dose that works for them for longer, or returning to the last dose they tolerated for a while before trying the higher dose again. That decision is your prescriber's.
  • As your coach I help you track your symptoms day by day, prepare for that conversation, and use food, fluid, fiber and training strategies that make each step easier. I never change or recommend a dose myself.

Message to send your prescriber

Copy it, fill in the brackets, and send it through your patient portal or bring it to your visit.

Hi, I started my new GLP-1 dose on [date] and since then I've had: [symptoms, how often, how bad].
These side effects are affecting [eating / work / sleep / training].
Could we talk about:
- staying on my current dose longer before increasing, or
- going back to my previous dose for a few weeks before trying again, or
- a smaller in-between step instead of the full jump?
Which symptoms should make me contact you right away?
Thank you.

Muscle and GLP-1s: what newer research suggests

In simple words: you may lose some muscle along with fat, but less than the headlines suggest, and lifting weights plus eating enough protein is how you protect it.

Protect your muscle

A 12-week strength plan designed around appetite changes and low-energy days.

Adults taking a prescribed GLP-1 medication

GLP-1 Strength Companion

A 3-day strength plan focused on keeping muscle while losing weight on a prescribed GLP-1 medication, with habits for appetite changes and hydration.

12 weeks · 2 workouts · every move animated

Show my workout →

Sources

Health coaching is not medical care. This page does not tell you whether a GLP-1 medicine is right for you, or how to dose one. Always follow your prescriber's instructions and the medication guide supplied with your prescription.